AKTX (STOCKS)
Akari Therapeutics plc ADR (0.01 USD)
$0.250500
+0.008400 (+3.47%)
Prev close: $0.242100
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Abizer Gaslightwala
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $8.22M
- Employees
- 12
- P/E (TTM)
- -0.04
- P/B (TTM)
- 0.35
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Nonoperating Income/Loss | $2.47M |
| Selling, General, and Administrative Expenses | $10.19M |
| Research and Development | $2.98M |
| Operating Income/Loss | -$19.33M |
| Income/Loss From Continuing Operations After Tax | -$16.86M |
| Income/Loss From Continuing Operations Before Tax | -$16.86M |
| Net Income/Loss | -$15.77M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$15.77M |
| Net Income/Loss Available To Common Stockholders, Basic | -$15.77M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.00 |
| Diluted Earnings Per Share | $0.00 |
| Basic Average Shares | 65,944,848,520 |
| Diluted Average Shares | 65,944,848,520 |
| Assets | $45.38M |
| Current Assets | $2.95M |
| Prepaid Expenses | $349.00K |
| Other Current Assets | $2.60M |
| Noncurrent Assets | $42.43M |
| Liabilities | $22.69M |
| Current Liabilities | $15.57M |
| Accounts Payable | $10.84M |
| Other Current Liabilities | $4.72M |
| Noncurrent Liabilities | $7.12M |
| Equity | $22.69M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $22.69M |
| Liabilities And Equity | $45.38M |
| Net Cash Flow From Operating Activities | -$9.65M |
| Net Cash Flow From Operating Activities, Continuing | -$9.65M |
| Net Cash Flow From Investing Activities | -$1.10M |
| Net Cash Flow From Investing Activities, Continuing | -$1.10M |
| Net Cash Flow From Financing Activities | $9.57M |
| Net Cash Flow From Financing Activities, Continuing | $9.57M |
| Exchange Gains/Losses | $2.00K |
| Net Cash Flow | -$1.19M |
| Net Cash Flow, Continuing | -$1.19M |
| Comprehensive Income/Loss | -$15.62M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$15.66M |
| Other Comprehensive Income/Loss | -$10.02M |
| Other Comprehensive Income/Loss Attributable To Parent | -$218.00K |